U.S. Media Stock News

Why the KRONOS MMR permit filing matters for NANO Nuclear Energy stock NANO Nuclear Energy (NNE) has just moved its KRONOS MMR microreactor into a new phase, with a Construction Permit Application filed to the U.S. Nuclear Regulatory Commission in partnership with the University of Illinois Urbana Champaign. See our latest analysis for NANO Nuclear Energy. The KRONOS MMR permit news arrives after a mixed run for the shares, with a 1-day share price return of 4.8% and 7-day return of 5.37%...

Ladder Capital (LADR) has been drawing attention after recent share performance, with a one-month return of a 5.7% decline and a past three-month return of an 11.9% decline, prompting closer scrutiny of its fundamentals. See our latest analysis for Ladder Capital. At a share price of $9.78, Ladder Capital’s recent 1 day and 7 day share price returns have been positive, but the 30 day and year to date share price returns remain negative, while multi year total shareholder returns are positive...

Recent analyst updates on lululemon athletica (LULU) followed fiscal Q4 and full year results, with attention on below consensus Q1 guidance and founder Chip Wilson’s renewed push for board and leadership changes. See our latest analysis for lululemon athletica. The share price has been under pressure, with a 30 day share price return of 10.08% and a 90 day share price return of 26.13%. At the same time, the 1 year total shareholder return of 40.95% and 3 year total shareholder return of...

AtriCure recently reported its fourth-quarter 2025 results, highlighting 15% revenue growth that underscored continued demand for its cardiac and pain management devices. The contrast between solid operating performance and more cautious analyst commentary is drawing attention to how market opinion is evolving around AtriCure’s longer-term prospects. We’ll now examine how AtriCure’s strong quarterly revenue performance interacts with shifting analyst sentiment to reshape its existing...

In late March 2026, Incyte reported 54-week Phase 3 STOP-HS data showing durable efficacy and a consistent safety profile for its oral JAK1 inhibitor povorcitinib in adults with moderate to severe hidradenitis suppurativa. Separately, Adagene recently announced a clinical collaboration under which Incyte will run a Phase 1 trial combining its TGFßR2 × PD-1 bispecific antibody INCA33890 with Adagene’s muzastotug in hard-to-treat microsatellite stable colorectal cancer, underscoring Incyte’s...

In recent days, analyst downgrades for Warrior Met Coal have cut consensus earnings estimates for 2026 and 2027, reflecting mounting concerns about weaker demand for coal amid the global shift toward cleaner energy and tightening environmental regulations. This reassessment of Warrior Met Coal’s earnings outlook, coupled with a bearish industry stance from Zacks Equity Research, highlights how sector-wide decarbonization pressures may be reshaping expectations for the company’s long-term...

VeriSign recently announced that its first-quarter 2026 earnings release and teleconference, held on April 23, provided investors with updated insights into its domain registry and internet infrastructure operations. Analysts grew more optimistic ahead of this event, with earnings forecasts pointing to a profit per share increase and a generally supportive consensus view on the business. With analysts becoming more optimistic ahead of earnings, we’ll examine how this strengthened sentiment...

In recent days, UBS analyst Joshua Spector upgraded Perimeter Solutions from a neutral stance to a buy rating, signaling greater confidence in the company’s outlook. This shift in analyst sentiment highlights how external research views can influence investor perception of Perimeter Solutions’ business direction and execution risks. Next, we will examine how UBS’s upgraded view on Perimeter Solutions shapes the company’s investment narrative and potential risk-reward profile. Uncover the...

VEON (VEON) is back in focus after its JazzCash unit in Pakistan reached 1 million Raast QR enabled merchants, highlighting how the group’s digital payments and AI heavy strategy could matter for shareholders. See our latest analysis for VEON. Recent announcements on JazzCash, sovereign AI, and Kyivstar’s Nasdaq listing have arrived during a softer patch for the shares, with a 30 day share price return of 10.27% decline and a year to date share price return of 9.45% decline, even as the 1...

Progyny stock performance sets the stage for closer review Progyny (PGNY) has been under pressure, with the share price showing a 1.5% decline over the past day, a 5.8% decline over the past month, and a 35.5% decline over the past 3 months. These moves, alongside recent financial figures such as US$1.29b in revenue and US$58.52m in net income, are prompting some investors to reassess what they are paying for the company’s fertility and family benefits business. See our latest analysis for...

Analyst reactions and trial setback keep focus on BioNTech (NasdaqGS:BNTX) Recent analyst actions, a CEO transition, softer COVID guidance, and the halt of recruitment in a major US COVID-19 vaccine trial have kept investor attention squarely on BioNTech (NasdaqGS:BNTX). See our latest analysis for BioNTech. Recent price action reflects that tension, with a 6.42% 7 day share price return and a 1.97% move higher in the latest session coming after a 10.56% 1 month share price decline and a...

Why Frontline’s board changes matter against a tighter tanker market Recent disruptions in the Strait of Hormuz are forcing crude tankers onto longer routes, tightening vessel supply and lifting spot charter rates, which puts Frontline (NYSE:FRO) in focus for investors tracking tanker earnings sensitivity. See our latest analysis for Frontline. Frontline’s latest share price of US$36.60 sits on top of strong recent momentum, with a 90 day share price return of 77.84% and a 1 year total...

Why Chesapeake Utilities stock is back in focus Chesapeake Utilities (CPK) is back on investors' radars after a fresh round of leadership moves, including naming Michael Galtman as chief transformation officer and Melissa Barnes as vice president and chief accounting officer. These appointments tie directly to the company's enterprise resource planning project and finance function, giving investors new information about how Chesapeake Utilities is organizing leadership around its long term...

Boot Barn Holdings recently reported past quarterly results that exceeded revenue and earnings estimates, fueled by higher transaction volumes and continued new store openings, and raised its guidance for the coming fiscal year while outlining additional expansion plans. Despite these stronger-than-expected results, investor reactions have been mixed as some shareholders focus on the company’s cautious near-term outlook and the risk of slower growth ahead. Now we’ll examine how the...

Microsoft (NasdaqGS:MSFT) has announced a $10b AI and cloud infrastructure investment in Japan. The plan includes partnerships with major Japanese companies and a goal to train one million AI engineers by 2029. This is described as one of Microsoft’s largest technology infrastructure projects in Asia. For investors tracking Microsoft at a current share price of $373.46, this move adds a fresh development to the wider AI and cloud story around NasdaqGS:MSFT. The company’s long term share...

On March 31, 2026, Ternium S.A. filed its 2025 Form 20-F with the SEC, outlining its operational, financial and sustainability progress, including investments in low-carbon steelmaking technologies and advanced products for the energy transition. The filing gives investors a more detailed view of how Ternium is positioning itself as a supplier of lower-emission steel solutions across the Americas, with an emphasis on sustainable mobility and transparency in reporting. Now, we’ll explore how...

Understanding Mohawk Industries after recent share performance Mohawk Industries (MHK) has drawn attention after its share price showed a 2.7% decline over the past day, together with negative returns over the month and past 3 months, prompting closer inspection of its fundamentals. See our latest analysis for Mohawk Industries. At a share price of US$96.80, Mohawk Industries has seen its 1 month share price return of a 10.95% decline extend a weaker pattern that leaves the year to date share...

On 2 April 2026, ACM Research, Inc. reorganized its expanding semiconductor equipment portfolio into the ACM Planetary Family, grouping tools into eight process-based series spanning cleaning, advanced packaging, electroplating, furnace, track, PECVD, panel-level packaging and stress-free polishing applications. This shift from a single-product focus to a clearer, process-aligned multi-product lineup highlights ACM's intent to strengthen technology differentiation and better match complex...

In early April 2026, Immunovant reported topline data showing that its two Phase 3 GO studies of batoclimab in adults with active, moderate-to-severe thyroid eye disease did not meet the primary endpoint of a 2mm or greater proptosis responder rate at Week 24, although safety remained consistent with prior findings and no new signals emerged. The company highlighted that proptosis improvements were greater during the initial high-dose period, reinforcing the role of deeper IgG suppression,...

Sharplink: Business mix and recent share performance Sharplink (SBET) has drawn fresh attention after recent share price volatility, with the stock showing a 4.2% decline over the past day, a 2.5% gain over the past week, and weaker returns over the past month and past 3 months. Over the past year, Sharplink’s total return is close to 99%, while its 3 year total return reflects a loss of about 87%. Year to date, the stock is down about 36%, giving the company a market value of roughly...

Agilent Technologies (A) has just added two fresh product milestones: the BioTek Cytation 9 cell imaging multimode reader and an FDA cleared PD-L1 IHC 22C3 companion diagnostic, giving investors new context for thinking about the stock. See our latest analysis for Agilent Technologies. These product launches and the recent dividend announcement come against a mixed backdrop, with a 7 day share price return of 4.75%, a 90 day share price return of 16.29%, and a 3 year total shareholder return...

In late March 2026, Hasbro disclosed a cyberattack that forced parts of its manufacturing and shipping systems offline, prompting business continuity measures and warning of potential delivery delays lasting several weeks. The incident tests the resilience of Hasbro’s increasingly streamlined supply chain and its efforts to improve efficiency and reliability across omni-channel distribution. We’ll now examine how this cyberattack, and the risk of weeks-long product delays, may affect...

In recent days Peloton Interactive reported margin expansion and adjusted EBITDA growth while unveiling plans to roll out its Peloton Commercial Series bikes and treadmills for gyms from late 2026, alongside leadership changes including the appointment of Sarah Robb O’Hagan as Chief Content and Member Development Officer and the departure of CFO Liz Coddington. These developments highlight Peloton’s push to extend beyond at-home fitness into commercial facilities and connected wellness,...

Fund addition sharpens focus on ADT The addition of ADT (ADT) to Ariel Focus Fund, together with its partnerships with Google and State Farm, has put fresh attention on the security provider’s recurring revenue model and perceived competitive position. See our latest analysis for ADT. At a share price of $6.62, ADT has a 90 day share price return of 17.35% decline and a year to date share price return matching that move, while the 1 year total shareholder return of 14.66% decline contrasts...